10x Genomics Inc (TXG)
22.68
+0.09
(+0.40%)
USD |
NASDAQ |
May 28, 16:00
22.64
-0.04
(-0.18%)
After-Hours: 07:56
10x Genomics Cash from Financing (Quarterly): 1.638M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.638M |
| December 31, 2023 | 5.613M |
| September 30, 2023 | 4.374M |
| June 30, 2023 | 7.096M |
| March 31, 2023 | -3.414M |
| December 31, 2022 | 5.001M |
| September 30, 2022 | 2.039M |
| June 30, 2022 | 6.36M |
| March 31, 2022 | 2.417M |
| December 31, 2021 | 8.903M |
| September 30, 2021 | 6.683M |
| Date | Value |
|---|---|
| June 30, 2021 | 16.19M |
| March 31, 2021 | 3.518M |
| December 31, 2020 | 7.706M |
| September 30, 2020 | 486.97M |
| June 30, 2020 | 8.051M |
| March 31, 2020 | -33.82M |
| December 31, 2019 | -1.107M |
| September 30, 2019 | 415.64M |
| June 30, 2019 | -0.864M |
| March 31, 2019 | 0.923M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-33.82M
Minimum
Mar 2020
486.97M
Maximum
Sep 2020
47.45M
Average
5.307M
Median
Cash from Financing (Quarterly) Benchmarks
| Teladoc Health Inc | 1.751M |
| American Shared Hospital Services | 2.282M |
| Novo Integrated Sciences Inc | 0.0032M |
| Astrana Health Inc | 106.35M |
| Cryo-Cell International Inc | 0.539M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.72M |
| Cash from Investing (Quarterly) | 10.63M |
| Free Cash Flow | -73.95M |
| Free Cash Flow Per Share (Quarterly) | -0.1561 |
| Free Cash Flow to Equity (Quarterly) | -18.64M |
| Free Cash Flow to Firm (Quarterly) | -18.64M |
| Free Cash Flow Yield | -2.76% |